Becton Dickinson Total Assets 2010-2024 | BDX
Becton Dickinson total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Becton Dickinson total assets for the quarter ending June 30, 2024 were $55.582B, a 4.84% increase year-over-year.
- Becton Dickinson total assets for 2023 were $52.78B, a 0.29% decline from 2022.
- Becton Dickinson total assets for 2022 were $52.934B, a 1.73% decline from 2021.
- Becton Dickinson total assets for 2021 were $53.866B, a 0.27% decline from 2020.
Becton Dickinson Annual Total Assets (Millions of US $) |
2023 |
$52,780 |
2022 |
$52,934 |
2021 |
$53,866 |
2020 |
$54,012 |
2019 |
$51,765 |
2018 |
$53,904 |
2017 |
$37,734 |
2016 |
$25,586 |
2015 |
$26,478 |
2014 |
$12,447 |
2013 |
$12,149 |
2012 |
$11,361 |
2011 |
$10,430 |
2010 |
$9,651 |
2009 |
$9,305 |
Becton Dickinson Quarterly Total Assets (Millions of US $) |
2024-06-30 |
$55,582 |
2024-03-31 |
$54,157 |
2023-12-31 |
$52,274 |
2023-09-30 |
$52,780 |
2023-06-30 |
$53,017 |
2023-03-31 |
$54,394 |
2022-12-31 |
$53,129 |
2022-09-30 |
$52,934 |
2022-06-30 |
$53,199 |
2022-03-31 |
$54,786 |
2021-12-31 |
$53,363 |
2021-09-30 |
$53,866 |
2021-06-30 |
$54,333 |
2021-03-31 |
$54,921 |
2020-12-31 |
$54,748 |
2020-09-30 |
$54,012 |
2020-06-30 |
$53,959 |
2020-03-31 |
$53,516 |
2019-12-31 |
$51,952 |
2019-09-30 |
$51,765 |
2019-06-30 |
$52,233 |
2019-03-31 |
$52,598 |
2018-12-31 |
$52,932 |
2018-09-30 |
$53,904 |
2018-06-30 |
$53,977 |
2018-03-31 |
$54,573 |
2017-12-31 |
$55,363 |
2017-09-30 |
$37,734 |
2017-06-30 |
$37,166 |
2017-03-31 |
$24,121 |
2016-12-31 |
$24,318 |
2016-09-30 |
$25,586 |
2016-06-30 |
$26,016 |
2016-03-31 |
$26,236 |
2015-12-31 |
$26,046 |
2015-09-30 |
$26,478 |
2015-06-30 |
$27,079 |
2015-03-31 |
$28,293 |
2014-12-31 |
$18,503 |
2014-09-30 |
$12,447 |
2014-06-30 |
$12,374 |
2014-03-31 |
$12,250 |
2013-12-31 |
$12,035 |
2013-09-30 |
$12,149 |
2013-06-30 |
$11,587 |
2013-03-31 |
$11,630 |
2012-12-31 |
$11,629 |
2012-09-30 |
$11,361 |
2012-06-30 |
$11,025 |
2012-03-31 |
$11,195 |
2011-12-31 |
$11,413 |
2011-09-30 |
$10,430 |
2011-06-30 |
$10,621 |
2011-03-31 |
$10,344 |
2010-12-31 |
$10,071 |
2010-09-30 |
$9,651 |
2010-06-30 |
$9,032 |
2010-03-31 |
$8,943 |
2009-12-31 |
$9,094 |
2009-09-30 |
$9,305 |
2009-06-30 |
$8,849 |
2009-03-31 |
$7,576 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$69.388B |
$19.372B |
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|